TABLE 2.
Indicator | Type of Evidence |
---|---|
Long-lasting improvement of motor state in “off” condition | Indirect evidence |
Long-lasting reduction of the requirement of the DA drugs | Indirect evidence |
PET imaging with labeled Levodopa | Indirect evidence |
Correlation, PET/motor measurements | Indirect evidence |
Functional improvement of movement-related brain activation (PET/MRI) | Indirect evidence |
Demonstration of DA release by transplant | Indirect evidence |
Postmortem examination of grafted brain | Direct evidence |